Display options
Share it on

Cureus. 2018 Mar 29;10(3):e2394. doi: 10.7759/cureus.2394.

Fusion of Intraoperative Transrectal Ultrasound Images with Post-implant Computed Tomography and Magnetic Resonance Imaging.

Cureus

Guila Delouya, Jean-Francois Carrier, Renée Xavier-Larouche, Yannick Hervieux, Dominic Béliveau-Nadeau, David Donath, Daniel Taussky

Affiliations

  1. Department of Radiation Oncology, Centre hospitalier de l'Université de Montréal (CHUM).

PMID: 29850389 PMCID: PMC5973483 DOI: 10.7759/cureus.2394

Abstract

Purpose To compare the impact of the fusion of intraoperative transrectal ultrasound (TRUS) images with day 30 computed tomography (CT) and magnetic resonance imaging (MRI) on prostate volume and dosimetry. Methods and materials Seventy-five consecutive patients with CT and MRI obtained on day 30 with a Fast Spin Echo T2-weighted magnetic resonance (MR) sequence were analyzed. A rigid manual registration was performed between the intraoperative TRUS and day-30 CT based on the prostate volume. A second manual rigid registration was performed between the intraoperative TRUS and the day-30 MRI. The prostate contours were manually modified on CT and MRI. The difference in prostate volume and dosimetry between CT and MRI were compared. Results Prostate volume was on average 8% (standard deviation (SD) ± 16%) larger on intraoperative TRUS than on CT and 6% (18%) larger than on MRI. In 48% of the cases, the difference in volume on CT was > 10% compared to MRI. The difference in prostate volume between CT and MRI was inversely correlated to the difference in D90 (minimum dose that covers 90% of the prostate volume) between CT and MRI (r = -0.58, P < .001). A D90 < 90% was found in 5% (n = 4) on MRI and in 10% (n = 7) on CT (Fisher exact test one-sided P = .59), but in no patient was the D90 < 90% on both MRI and CT. Conclusions When fusing TRUS images with CT and MRI, the differences in prostate volume between those modalities remain clinically important in nearly half of the patients, and this has a direct influence on how implant quality is evaluated.

Keywords: dosimetry; mri; permanent brachytherapy

Conflict of interest statement

The authors have declared that no competing interests exist.

References

  1. Brachytherapy. 2014 Jan-Feb;13(1):42-3 - PubMed
  2. Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):1912-7 - PubMed
  3. Radiother Oncol. 2010 Aug;96(2):166-71 - PubMed
  4. Brachytherapy. 2014 Jan-Feb;13(1):68-74 - PubMed
  5. Strahlenther Onkol. 2011 Mar;187(3):183-90 - PubMed
  6. Radiat Oncol. 2013 Jul 25;8:188 - PubMed
  7. Radiother Oncol. 2010 Dec;97(3):572-8 - PubMed
  8. Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):1944-8 - PubMed
  9. Int J Radiat Oncol Biol Phys. 2011 Jul 1;80(3):728-34 - PubMed
  10. Int J Radiat Oncol Biol Phys. 2007 Mar 15;67(4):1238-47 - PubMed
  11. Int J Radiat Oncol Biol Phys. 2002 Nov 1;54(3):703-11 - PubMed
  12. Radiographics. 2013 May;33(3):741-61 - PubMed
  13. Int J Radiat Oncol Biol Phys. 2014 Oct 1;90(2):320-8 - PubMed
  14. Brachytherapy. 2014 Jan-Feb;13(1):32-41 - PubMed
  15. Brachytherapy. 2002;1(2):66-73 - PubMed
  16. Int J Radiat Oncol Biol Phys. 2007 Feb 1;67(2):327-33 - PubMed
  17. Int J Radiat Oncol Biol Phys. 2005 Jul 15;62(4):974-80 - PubMed
  18. Brachytherapy. 2013 Jan-Feb;12(1):38-43 - PubMed

Publication Types